OpenScience.ink

3 weeks ago • Nutrients

How Belief in Social Media Stories About Weight-Loss Drugs Relates to Willingness to Use Combined Obesity Treatments and SupportPerceived Credibility of Social Media Narratives About GLP-1 Receptor Agonists and Acceptance of Integrated Obesity Care: Implications for Nutrition and Lifestyle Support.

🎖️ Top 10% JournalArticle

3 weeks ago • International journal of molecular sciences

How GLP-1 Receptor Activators May Affect Obstructive Sleep Apnea: Understanding Mechanisms and Possible TreatmentsGLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications.

📖 Top 20% JournalArticle

3 weeks ago • Nutrients

Skeletal Muscle Health During Incretin-Based Treatment in Patients with Diabetes and ObesityBeyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity.

🎖️ Top 10% JournalArticle

3 weeks ago • Nutrients

Do Patients Using GLP-1 Medicines for Weight Loss Need Guided Diet Support? Insights from Weight Loss Surgery ProgramsDo Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways.

🎖️ Top 10% JournalArticle

3 weeks ago • Biology

How GLP-1 Drugs Help with Weight Loss and Ways to Improve Their EffectivenessFor Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?

📖 Top 20% JournalArticle

3 weeks ago • Pharmaceuticals (Basel, Switzerland)

Effects of Semaglutide Use During Pregnancy Based on FAERS DataSemaglutide Exposure During Pregnancy: Results from the FAERS Database.

📖 Top 20% JournalArticle

3 weeks ago • Endocrinology

Key roles of a β-cell protein and sex in controlling α-cell shape and functionβ-cell 14-3-3-ζ and sex are key regulators of α-cell form and function.

🎖️ Top 10% JournalArticle

3 weeks ago • MedComm

Metabolic Syndrome: Causes and Possible TreatmentsMetabolic Syndrome: From Mechanisms to Therapeutic Interventions.

🥉 Top 5% JournalArticle

4 weeks ago • The FEBS journal

Effects of GLP-1 drugs on gut bacteria in type 2 diabetesEffects of GLP-1 agonists on the gut microbiota in type 2 diabetes mellitus: a systematic review.

🥉 Top 5% JournalArticle

4 weeks ago • Current psychiatry reports

Brain effects and possible mental health impacts of GLP-1 and combined GIP/GLP-1 receptor drugs based on systematic evaluationGLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.

🥉 Top 5% JournalArticle

1 month ago • Frontiers in public health

Quality and trustworthiness of semaglutide health information on Chinese short-video apps Bilibili and TikTokQuality and reliability of semaglutide-related health information on Chinese short-video platforms: a cross-sectional study of Bilibili and TikTok.

📖 Top 20% JournalArticle

1 month ago • Diabetologia

Dulaglutide versus insulin effects on metabolism and artery disease risk in teenagers with thalassaemia-related diabetesDulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA).

🥈 Top 2% JournalArticle

2 weeks ago • Medicine

Tirzepatide helps hard-to-treat diabetes in an adult woman with Prader-Willi syndromeCase report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome.

📖 Top 50% JournalCase Reports

2 days ago • BMJ open

Semaglutide as an additional treatment for obesity in teens taking antipsychotic drugs: plan for a first feasibility studySemaglutide as adjunct treatment for obesity in adolescents receiving antipsychotic medication (the GOAL trial): protocol for a single-arm, open-label feasibility study.

📖 Top 20% JournalClinical Trial Protocol

3 days ago • Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Obesity, hormone-based diabetes treatments, and heart disease in womenObesity, incretin-based therapies, and cardiovascular disease in women.

📖 Top 30% JournalArticle

6 days ago • Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

GLP-1 receptor drugs and their effects on body weight and heart healthEffects of GLP-1 receptor agonists on body weight and cardiovascular outcomes: a review.

📖 Top 30% JournalArticle

1 week ago • Hormones (Athens, Greece)

Improvement in small nerve damage seen in the eye after semaglutide treatment: a case report and reviewImprovement of small fiber neuropathy assessed by corneal confocal microscopy following semaglutide treatment: a case report and literature review.

📖 Top 30% JournalArticle

1 week ago • Obesity science & practice

Malnutrition and Metabolic Problems Linked to High-Potency Incretin Treatments: A Review and AnalysisA Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy.

📖 Top 30% JournalArticle

3 weeks ago • Frontiers in neuroscience

Neuroprotective effects of GLP-1 and GIP drugs in Alzheimer's and Parkinson's diseaseGLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.

📖 Top 20% JournalArticle

3 weeks ago • Frontiers in neurology

Exendin-4 as a treatment for brain injury caused by inflammation in unborn babiesExendin-4 as a multi-target therapy for Fetal Inflammatory Response Syndrome-induced brain injury.

📖 Top 20% JournalArticle